A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

Trial Identifier: 3543-017
Sponsor: MSD
Start Date: May 2024
Primary Completion Date: December 2034
Study Completion Date: December 2034
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary - English

Trial Locations

Country Location
Australia, New South Wales Camperdown, New South Wales, Australia, 2050
Australia, New South Wales St Leonards, New South Wales, Australia, 2065
Australia, Queensland Buderim, Queensland, Australia, 4556
Australia, Queensland Southport, Queensland, Australia, 4215
Australia, South Australia Adelaide, South Australia, Australia, 5000
Australia, Victoria Clayton, Victoria, Australia, 3168
Hong Kong, N/A HKSAR, N/A, Hong Kong, N/A
Italy, Alessandria Alessandria, Italy, 15121
Italy, Bologna Bologna, Italy, 40138
Italy, Toscana Firenze, Toscana, Italy, 50134
Italy, Varese Varese, Italy, 21100
New Zealand, Auckland Auckland, New Zealand, 2025
New Zealand, Auckland Auckland, New Zealand, 0622
United Kingdom, Hammersmith and Fulham London, Hammersmith and Fulham, United Kingdom, W12 0HS
United Kingdom, Lincolnshire Boston, Lincolnshire, United Kingdom, PE21 9QS
United Kingdom, London, City of London, London, City of, United Kingdom, NW1 2PG
United Kingdom, London, City of London, London, City of, United Kingdom, SE1 9RT
United States, MI Ann Arbor, MI, United States, 48109
United States, NC Durham, NC, United States, 27705
United States, OH Columbus, OH, United States, 43210
United States, PA Pittsburgh, PA, United States, 15232